- Amended Statement of Ownership: Solicitation (SC 14D9/A)
May 09 2011 - 8:57AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(Rule 14d-101)
Solicitation/Recommendation Statement
Under Section 14(d)(4) of the
Securities Exchange Act of 1934
(Amendment No. 16)
CELERA CORPORATION
(Name of Subject Company)
CELERA CORPORATION
(Name of Persons Filing Statement)
Common Stock,
par value $0.01 per share
(Title of Class of Securities)
15100E106
(CUSIP Number of Class of Securities)
Kathy
Ordoñez
Chief Executive Officer
1401 Harbor Bay Parkway
Alameda, California 94502
(510) 749-4200
(Name, address and telephone number of persons authorized to receive
notices and communications on behalf of the persons filing statement)
With copies to:
Tad J. Freese
Latham & Watkins LLP
140 Scott Drive
Menlo Park, California 94025-3656
(650) 328-4600
¨
|
Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
|
Purpose of Amendment
This Amendment No. 16 amends and supplements the Solicitation/Recommendation Statement on Schedule 14D-9 as filed with the Securities and Exchange Commission (the
SEC
) on
March 28, 2011 (together with the exhibits thereto and as amended and supplemented from time to time, the
Schedule 14D-9
) by Celera Corporation, a Delaware corporation (the
Company
), relating to the tender
offer by Spark Acquisition Corporation (
Purchaser
), a Delaware corporation and a wholly owned subsidiary of Quest Diagnostics Incorporated, a Delaware corporation (
Parent
), to purchase all of the issued and
outstanding shares of common stock of the Company (
Shares
), at a price of $8.00 per Share, payable net to the holder in cash, without interest, subject to any withholding of taxes required by applicable law, upon the terms and
subject to the conditions set forth in the Offer to Purchase for Cash, dated March 28, 2011 (the
Offer
), and in the related Letter of Transmittal. The Offer is described in a Tender Offer Statement on Schedule TO filed by
Parent and Purchaser with the SEC on March 28, 2011.
Except as otherwise indicated, the information set forth in the Schedule 14D-9
remains unchanged. Capitalized terms used, but not defined, in this Amendment No.
16 have the meanings ascribed to them in the Schedule 14D-9.
Item 8.
|
Additional Information.
|
Item 8 of the Schedule 14D-9 is hereby amended and supplemented by adding the following at the end of Item 8:
Extension of Subsequent Offering Period.
On May 9,
2011, Parent issued a press release announcing that the Purchaser has extended the subsequent offering period for two days. The extended subsequent offering period will expire at 5:00 p.m. (New York City time) on Tuesday, May 10, 2011. The
subsequent offering period will not be further extended. The subsequent offering period was previously scheduled to expire at 5:00 p.m. (New York City time) on May 6, 2011. The Depositary has advised Parent that, as of 5:00 p.m. (New York City
time) on May 6, 2011, approximately 880,139 Shares had been tendered during the subsequent offering period. Purchaser has accepted all Shares for payment in accordance with the terms of the Offer. Purchaser now owns approximately 51,722,734
Shares, representing approximately 62.33% of the outstanding Shares and 59.30% of the Companys outstanding Shares on a fully diluted basis (as determined pursuant to the Merger Agreement). Stockholders who properly tender Shares during the
subsequent offering period (as extended) will receive the same $8.00 per Share in cash, without interest and subject to any withholding of taxes required by applicable law, which is the same amount per Share that was paid in the initial offering
period. Shares tendered during the subsequent offering period may not be withdrawn and may not be delivered by guaranteed delivery procedure. In addition, no Shares validly tendered during the initial offering period may be withdrawn during the
subsequent offering period. The full text of the press release by Parent announcing the extension of the subsequent offering period is filed as Exhibit (a)(9) hereto and is incorporated herein by reference.
Item 9 of the Schedule 14D-9 is hereby amended and supplemented by adding the following exhibit:
|
|
|
Exhibit
Number
|
|
Description
|
(a)(9)
|
|
Press release issued by Quest Diagnostics Incorporated on May 9, 2011 (incorporated by reference to Exhibit (a)(5)(L) to Schedule TO-T/A of Quest Diagnostics Incorporated and
Spark Acquisition Corporation, filed with the SEC on May 9, 2011).
|
After due inquiry and to the best of my knowledge and belief, I certify that the information
set forth in this statement is true, complete and correct.
|
|
|
Celera Corporation
|
|
|
By:
|
|
/s/ Scott K. Milsten
|
Name:
|
|
Scott K. Milsten
|
Title:
|
|
Senior Vice President, General Counsel and Secretary
|
Dated: May 9, 2011
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
|
|
(a)(9)
|
|
Press release issued by Quest Diagnostics Incorporated on May 9, 2011 (incorporated by reference to Exhibit (a)(5)(L) to Schedule TO-T/A of Quest Diagnostics Incorporated and
Spark Acquisition Corporation, filed with the SEC on May 9, 2011).
|
Celera Corp. (MM) (NASDAQ:CRA)
Historical Stock Chart
From May 2024 to Jun 2024
Celera Corp. (MM) (NASDAQ:CRA)
Historical Stock Chart
From Jun 2023 to Jun 2024